Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6054.0000 -45.50 (-0.75%)
NSE Sep 17, 2025 15:29 PM
Volume: 414.0K
 

6054.00
-0.75%
Ashika Research
Divi's is well-positioned in the Contract/Custom Research and Manufacturing Services (CRAMS) space, given its strong relationships with innovators, thus with presence...
Number of FII/FPI investors increased from 922 to 990 in Jun 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended